Log in
Enquire now
‌

US Patent 10577427 Integral membrane protein display on poxvirus extracellular enveloped virions

Patent 10577427 was granted and assigned to Vaccinex, Inc on March, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Vaccinex, Inc
Current Assignee
‌
Vaccinex, Inc
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10577427
Date of Patent
March 3, 2020
Patent Application Number
16091077
Date Filed
April 21, 2017
Patent Citations
‌
US Patent 10111950 Modified glycolipids and methods of making and using the same
‌
US Patent 10301393 Methods of treating multiple sclerosis using anti-CD20 antibodies
Patent Primary Examiner
‌
Barry A Chestnut
Patent abstract

This disclosure provides compositions and methods for expressing and displaying isolated integral membrane proteins (IMPs) or fragments thereof in a native conformation for use in the screening, selecting, and identifying of antibodies or antibody-like molecules that bind to a target IMP of interest.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10577427 Integral membrane protein display on poxvirus extracellular enveloped virions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.